跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BM-20
首页
药物
BM-20
BM-20
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
T CELLS MODIFIED TO EXPRESS MUTATED CXCR4 OR PARTIALLY DELETED AND USES THEREOF
US 2024083973 A1
申请人: ECOLE NORMALE SUPERIEURE LYON
优先权: 2019
EP
US
WO
4 件公开
Color material compound
US 12209185 B2
申请人: DAINIPPON INK & CHEMICALS
优先权: 2019
CN
US
2 件公开
Bimetallic catalyst for preparing furfuryl alcohol by furfural selective hydrogenation and preparation method and application thereof
CN 110193370 A
申请人: UNIV JIANGXI SCI & TECHNOLOGY
优先权: 2019
CN
一种制备BM-MSCs条件培养基的方法、条件培养基以及应用
CN 112410303 B
申请人: 广东省人民医院
优先权: 2019
CN
Method for preparing culture medium for efficiently expressing paracrine RG1-BM-MSC, conditioned culture medium and application
CN 112553153 A
申请人: GUANGDONG PROVINCIAL PEOPLES HOSPITAL
优先权: 2020
CN
Preparation method of exosome scar repair gel
CN 114983920 A
申请人: WUHAN WUZHOU RUNDA BIOMEDICAL TECH CO LTD
优先权: 2022
CN
New application of 20 (S)-protopanoxadiol in delaying senescence of bone marrow mesenchymal stem cells
CN 120485113 A
申请人: HANGZHOU THIRD PEOPLES HOSPITAL HANGZHOU HUIMIN HOSPITAL ZHEJIANG UNIV OF TRADITIONAL CHINESE MEDICI
优先权: 2025
CN
药物
反馈